Vistagen Therapeutics Inc (VTGN) Stock Price, Quote, News & History

VTGNNASDAQ
$0.2970
-0.003-1.00%
At close: Aug 5, 5:00 PM EST
$0.2911
-0.0059-1.99%
After Hours: 7:58 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-66.44M
Investing Cash Flow (TTM)
-877.00K
Financing Cash Flow (TTM)
30.97M
Free Cash Flow (TTM)
-66.59M
Capital Expenditure (TTM)
-151.00K
Net Change in Cash (TTM)
-36.34M

Analyst Rating and Forecast

12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$31.43M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
8.74
PB Ratio (TTM)
0.36
Earnings Yield % (TTM)
-628.00%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.80

Company Debt

Total Debt
$96.00K
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$30.79M
Debt to Equity
0.03
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-$925.00K

Key Statistics

Open
$0.27
Close
$0.30
Volume / Avg.
5.54M / 3.94M
Day Range
$0.27 - $0.30
52 Wk Range
0.20 - 5.14
Market Cap
$11.94M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
47
Short Interest
3.9%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, a...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Vistagen Therapeutics (VTGN) stock?

A

You can purchase shares of Vistagen Therapeutics (NASDAQ:VTGN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Vistagen Therapeutics (VTGN) competitors?

A

There are no as such competitors for Vistagen Therapeutics.

Q

What is the forecast, or price target, for Vistagen Therapeutics (VTGN) stock?

A

Vistagen Therapeutics has a consensus price target of $6.45.

Q

What is the current price for Vistagen Therapeutics (VTGN)?

A

The stock price for Vistagen Therapeutics (NASDAQ: VTGN) is $0.2911 last updated August 5, 2026 at 7:58 PM EDT.

Q

Does Vistagen Therapeutics (VTGN) pay a dividend?

A

There are no upcoming dividends for Vistagen Therapeutics.

Q

When is Vistagen Therapeutics (NASDAQ:VTGN) reporting earnings?

A

Vistagen Therapeutics does not have any upcoming earnings scheduled.

Q

Is Vistagen Therapeutics (VTGN) going to split?

A

There is no upcoming split for Vistagen Therapeutics.

Q

What sector and industry does Vistagen Therapeutics (VTGN) operate in?

A

Vistagen Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.